Literature DB >> 8998487

Basal cell carcinomas cause little handicap.

S Blackford1, D Roberts, M S Salek, A Finlay.   

Abstract

Basal cell carcinoma (BCC) is the most common type of skin cancer and the incidence of BCC is expected to rise, with increased demand on dermatology resources. Little is known of the effect on people's lives of having skin cancer. The aim of this study was to quantify the handicap caused gy basal cell carcinomas before and after therapy. Forty-four patients (22 males, mean age = 65 yrs, range = 35-81 yrs) with 48 BCCs were recruited and 37 patients completed the study. Each patient completed the UK Sickness Impact Profile (UKSIP) and the Dermatology Life Quality Index (DLQI) at the initial visit to the dermatology clinic, 1 week after treatment and 3 months after treatment. Lesions had been present for a mean of 25 months (range = 1-240 months), their mean diameter was 9.6mm (range = 3-35mm) and the sites were head and neck (79%), trunk (17%) and limbs (4%). There was no relationship between the quality of life score and size of lesion. Overall the scores at presentation were very low, rising 1 week after treatment and falling to below the initial scores at 3 months (mean UKSIP 0.4%, 0.7%, 0.13%; mean DLQI 5.3% 8.7%, 1.2%). BCCs cause little handicap. This may explain the delay in seeking medical attention and should be considered in planning public health education about BCCs.

Entities:  

Mesh:

Year:  1996        PMID: 8998487     DOI: 10.1007/bf00434740

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  7 in total

1.  Validation of Sickness Impact Profile and Psoriasis Disability Index in Psoriasis.

Authors:  A Y Finlay; G K Khan; D K Luscombe; M S Salek
Journal:  Br J Dermatol       Date:  1990-12       Impact factor: 9.302

2.  A psychosocial assessment of patients with basal cell carcinoma.

Authors:  K I Holfeld; D J Hogan; M Eldemire; P R Lane
Journal:  J Dermatol Surg Oncol       Date:  1990-08

3.  Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

Authors:  A Y Finlay; G K Khan
Journal:  Clin Exp Dermatol       Date:  1994-05       Impact factor: 3.470

4.  The impact of generalized malignant melanoma on quality of life evaluated by the EORTC questionnaire technique.

Authors:  V Sigurdardóttir; C Bolund; Y Brandberg; M Sullivan
Journal:  Qual Life Res       Date:  1993-06       Impact factor: 4.147

5.  Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial.

Authors:  M S Salek; A Y Finlay; D K Luscombe; B R Allen; J Berth-Jones; R D Camp; R A Graham-Brown; G K Khan; R Marks; R J Motley
Journal:  Br J Dermatol       Date:  1993-10       Impact factor: 9.302

6.  Practical use of a disability index in the routine management of acne.

Authors:  R J Motley; A Y Finlay
Journal:  Clin Exp Dermatol       Date:  1992-01       Impact factor: 3.470

7.  Incidence of non-melanoma skin cancer in West Glamorgan, South Wales.

Authors:  D L Roberts
Journal:  Br J Dermatol       Date:  1990-03       Impact factor: 9.302

  7 in total
  18 in total

1.  A method to select an instrument for measurement of HR-QOL for cross-cultural adaptation applied to dermatology.

Authors:  A G de Tiedra; J Mercadal; X Badía; J M Mascaró; R Lozano
Journal:  Pharmacoeconomics       Date:  1998-10       Impact factor: 4.981

2.  Quality of life and clinical and demographic characteristics of patients with cutaneous squamous cell carcinoma submitted to tumor resection by double-bladed scalpel.

Authors:  Daniel Ongaratto Barazzetti; Pedro Henrique Ongaratto Barazzetti; Bárbara Thomé Cavalheiro; Jorge Bins Ely; Daniel Holthausen Nunes; Ana Maria Nunes de Faria Stamm
Journal:  An Bras Dermatol       Date:  2019-07-29       Impact factor: 1.896

3.  Development of the facial skin care index: a health-related outcomes index for skin cancer patients.

Authors:  B Alex Matthews; John S Rhee; Marcy Neuburg; Mary L Burzynski; Ann B Nattinger
Journal:  Dermatol Surg       Date:  2006-07       Impact factor: 3.398

4.  Creation of a quality of life instrument for nonmelanoma skin cancer patients.

Authors:  John S Rhee; B Alex Matthews; Marcy Neuburg; Mary Burzynski; Ann B Nattinger
Journal:  Laryngoscope       Date:  2005-07       Impact factor: 3.325

5.  Validation of a quality-of-life instrument for patients with nonmelanoma skin cancer.

Authors:  John S Rhee; B Alex Matthews; Marcy Neuburg; Brent R Logan; Mary Burzynski; Ann B Nattinger
Journal:  Arch Facial Plast Surg       Date:  2006 Sep-Oct

6.  Quality of Life in Patients with Non-melanoma Skin Cancer: Implications for Healthcare Education Services and Supports.

Authors:  Robabeh Abedini; Maryam Nasimi; Pedram Noormohammad Pour; Atie Moghtadaie; Hamid Reza Tohidinik
Journal:  J Cancer Educ       Date:  2019-08       Impact factor: 2.037

7.  The skin cancer index: clinical responsiveness and predictors of quality of life.

Authors:  John S Rhee; B Alex Matthews; Marcy Neuburg; Brent R Logan; Mary Burzynski; Ann B Nattinger
Journal:  Laryngoscope       Date:  2007-03       Impact factor: 3.325

8.  Identification of patients with nonmelanoma skin cancer using health maintenance organization claims data.

Authors:  Melody J Eide; Richard Krajenta; Dayna Johnson; Jordan J Long; Gordon Jacobsen; Maryam M Asgari; Henry W Lim; Christine C Johnson
Journal:  Am J Epidemiol       Date:  2009-12-06       Impact factor: 4.897

9.  Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial.

Authors:  Martin A Weinstock; Kachiu C Lee; Mary-Margaret Chren; Kimberly Marcolivio
Journal:  J Am Acad Dermatol       Date:  2009-04-26       Impact factor: 11.527

10.  Distress and coping strategies among patients with skin cancer.

Authors:  Nicole Roberts; Zofia Czajkowska; George Radiotis; Annett Körner
Journal:  J Clin Psychol Med Settings       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.